Table 1.

Primary and secondary antibodies. For VE-cadherin and KLF2, cells were permeabilized with 0.1% Triton-X 100 (Sigma) for 4 min. All cells were blocked with 10% horse serum (Vector, Burlington, ON) for 30 min and probed with antibodies diluted in 2% BSA (Sigma) for 30 min

Primary antibody, 1:50 dilution	Secondary antibody, 1:100 dilution
Anti-human VCAM-1, goat serum IgG (R&D Systems, Minneapolis, MN)	Alexa Fluor™ 488 donkey anti-goat IgG (Iinvitrogen, Burlington, ON)
Anti-human ICAM-1, mouse monoclonal IgG (Santa Cruz Biotechnology, Santa Cruz, CA)	Alexa Fluor™ 568 rabbit anti-mouse IgG (Invitrogen)
Anti-human VE-cadherin, rabbit IgG (Sigma, Oakville, ON)	Alexa Fluor™ 488 donkey anti-rabbit (Invitrogen)
Anti-human KLF2 (lung KLF), goat polyclonal IgG (Santa Cruz Biotechnology).	Alexa Fluor™ 546 donkey anti-goat (Invitrogen)